PAA 4.26% 22.5¢ pharmaust limited

Ann: Monepantel and monepantel sulfone COVID-19 anti-viral update, page-75

  1. 11,652 Posts.
    lightbulb Created with Sketch. 5900
    What I find exciting is the MPL has shown effect on the SARs and SARs2 viral family ,,, once the company communicate this clearly and what it exactly means then we should see wider market interest..

    https://hotcopper.com.au/data/attachments/3673/3673115-ef786191d47bdaa4e254655483bf0d75.jpg
    With the use of MPL you can be absolutely sure to cover off Covid and all its close Mutations and Variants,,,, just wish Management had sought to partner with someone as the time line is long and slow...............
    Surely an update on the MPL manufacturing this week? thoughts?
    Last edited by NZ Trader: 11/10/21
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
-0.010(4.26%)
Mkt cap ! $89.08M
Open High Low Value Volume
23.5¢ 23.5¢ 22.0¢ $170.5K 749.0K

Buyers (Bids)

No. Vol. Price($)
2 34313 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 24444 2
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
22.5¢
  Change
-0.010 ( 6.25 %)
Open High Low Volume
23.0¢ 23.0¢ 22.0¢ 246904
Last updated 15.57pm 14/06/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.